X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (242) 242
Publication (49) 49
Book Review (11) 11
Patent (5) 5
Book / eBook (3) 3
Conference Proceeding (3) 3
Dissertation (2) 2
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (177) 177
humans (175) 175
female (165) 165
adult (106) 106
uterine cervical neoplasms - virology (87) 87
cervical cancer (86) 86
cancer (70) 70
adolescent (68) 68
papillomavirus infections - virology (68) 68
human papillomavirus (65) 65
risk factors (63) 63
women (63) 63
oncology (60) 60
papillomaviridae - genetics (60) 60
papillomavirus infections (57) 57
cervical intraepithelial neoplasia - virology (56) 56
papillomaviridae - isolation & purification (52) 52
abridged index medicus (49) 49
middle aged (47) 47
papillomavirus infections - prevention & control (46) 46
cervical intraepithelial neoplasia (42) 42
infection (42) 42
vaccines (42) 42
young adult (42) 42
uterine cervical neoplasms - prevention & control (38) 38
papillomavirus infections - epidemiology (37) 37
young-women (37) 37
uterine cervical neoplasms - epidemiology (36) 36
article (34) 34
polymerase chain reaction (34) 34
intraepithelial neoplasia (33) 33
prevention (33) 33
public, environmental & occupational health (32) 32
risk (32) 32
uterine cervical neoplasms - pathology (32) 32
infectious diseases (30) 30
papillomaviridae - classification (30) 30
research (30) 30
uterine cervical neoplasms - diagnosis (29) 29
lesions (28) 28
papillomavirus infections - complications (28) 28
viruses (28) 28
cervical intraepithelial neoplasia - pathology (27) 27
cervical intraepithelial neoplasia - epidemiology (26) 26
cervical-cancer (26) 26
dna, viral - analysis (26) 26
genotype (26) 26
undetermined significance (26) 26
vaccination (26) 26
double-blind method (25) 25
prevalence (25) 25
randomized-trial (25) 25
colposcopy (24) 24
diagnosis (24) 24
health aspects (24) 24
hpv (24) 24
microbiology (24) 24
vaginal smears (24) 24
atypical squamous-cells (23) 23
female genital diseases and pregnancy complications (23) 23
follow-up studies (23) 23
immunology (23) 23
infections (23) 23
united-states (23) 23
aged (21) 21
cervical intraepithelial neoplasia - diagnosis (21) 21
epidemiology (21) 21
papillomavirus vaccines - administration & dosage (21) 21
papillomaviruses (21) 21
virology (21) 21
immunization (20) 20
papillomaviridae - immunology (20) 20
papillomavirus infections - diagnosis (20) 20
papillomavirus infections - pathology (19) 19
particle vaccine (19) 19
virus diseases (19) 19
analysis (18) 18
cervical intraepithelial neoplasia - prevention & control (18) 18
dna (18) 18
dna, viral - genetics (18) 18
obstetrics & gynecology (18) 18
medical screening (17) 17
neoplasia (17) 17
papillomavirus vaccines (17) 17
womens health (17) 17
human papillomavirus 16 - immunology (16) 16
management (16) 16
new mexico - epidemiology (16) 16
cervix uteri - virology (15) 15
human papillomavirus 16 - genetics (15) 15
human papillomavirus 18 - immunology (15) 15
papillomavirus vaccines - immunology (15) 15
base sequence (14) 14
case-control studies (14) 14
early detection of cancer (14) 14
papillomavirus vaccines - therapeutic use (14) 14
age factors (13) 13
cytology interpretations (13) 13
dna, viral - isolation & purification (13) 13
follow-up (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 1, pp. 20 - 21
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S1473-3099(16)30540-0 Byline: Cosette M Wheeler (a), Frank Struyf (b)... 
Infectious Disease | Studies | Clinical trials | Human papillomavirus | Vaccines | Pharmaceutical industry | Index Medicus
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2019, Volume 144, Issue 6, pp. 1460 - 1473
Journal Article
PLoS Pathogens, ISSN 1553-7366, 06/2015, Volume 11, Issue 6
  Cervical cancer is a multi-stage disease caused by human papillomaviruses (HPV) infection of cervical epithelial cells, but the mechanisms regulating disease... 
Human papillomavirus | Insulin-like growth factors | Rodents | Cervical cancer
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 5/2018, Volume 68, Issue 3, pp. 199 - 216
Timely follow-up for positive cancer screening results remains suboptimal and the evidence base to inform decisions on optimizing the timeliness of diagnostic... 
Neoplasm | early diagnosis | lung | cervix uteri | early detection of cancer | colon | mass screening | breast
Journal Article
Ca : a Cancer Journal for Clinicians, ISSN 0007-9235, 05/2018, Volume 68, Issue 3, p. 199
Timely follow-up for positive cancer screening results remains suboptimal,and the evidence base to inform decisions on optimizing the timeliness of... 
Systematic review | Medical screening | Cervix | Cancer
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2005, Volume 97, Issue 2, pp. 147 - 150
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 775 - 786
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the... 
Hematology, Oncology and Palliative Medicine | UNITED-STATES | AGED 16-26 YEARS | ONCOLOGY | PARTICLE VACCINE | NEOPLASIA | MAJOR CAPSID PROTEIN | YOUNG-WOMEN | CANCER | HUMAN-PAPILLOMAVIRUS INFECTION | LESIONS | EPITOPES | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer | Index Medicus
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 03/2005, Volume 191, Issue 6, pp. 969 - 976
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus... 
Hematology, Oncology and Palliative Medicine | COUNTRIES | ONCOLOGY | PARTICLE VACCINE | ADENOCARCINOMA | HPV VACCINATION | ADOLESCENT WOMEN | FOLLOW-UP | YOUNG-WOMEN | CANCER | CARCINOMA | HUMAN-PAPILLOMAVIRUS INFECTION | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer | Index Medicus
Journal Article